Chargement en cours...
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Gliclazide has been considered metabolized by CYP2C9. Its modified release formulation, gliclazide MR, shows low pharmacokinetic variability in Whites but high variability in Chinese. WHAT THIS STUDY ADDS: The results of this study show that the pharmacokine...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Science Inc
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2000619/ https://ncbi.nlm.nih.gov/pubmed/17298483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02846.x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|